The new COVID-19 vaccines could help the world — including the financial services sector — get back to normal. One question is how well the U.S. health care system will distribute the vaccine, and another question is how receptive Americans will be to getting new, rapidly developed vaccines. One clue may to be to look at take-up rates for two well-established vaccines against potentially deadly respiratory illnesses: influenza and pneumococcal pneumonia.
Resources
- Links to 2019 BRFSS survey resources are available here.
- An article about state-level COVID-19 hospitalization data is available here.
NOT FOR REPRINT
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.